ADRB3 and metabolic dysfunction-associated steatotic liver disease: The results of this study indicate that β3-AR stimulation can inhibit the expression of CD36 in the livers of NAFLD rats (Fig. 4d and f), which may be one of the mechanisms by which β3-AR helps ameliorate liver steatosis.